Amy Simon
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Amy Simon
The proxy statement of Beam Therapeutics Inc. reports total compensation of $2,802,044 for Amy Simon in fiscal 2025, including a base salary of $550,000. Disclosed compensation is on record for 3 fiscal years. Amy Simon has spoken on 1 earnings call across 1 company, most recently for Beam Therapeutics Inc. on February 24, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Beam Therapeutics Inc. (BEAM)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Beam Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- John Evans CEO, Chief Accounting Officer, Board Member
- Sravan Emany CFO
- Sravan K. Emany CFO
- Chirfi Guindo Board Member
- Christi Shaw Board Member
- Graham Cooper Board Member
- John Maraganore Board Member
- John Maraganore, Ph.D. Board Member
- Kathleen Walsh Board Member
- Mark Fishman Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Beam Therapeutics Inc. (BEAM) | CMO | $550,000 | $2,802,044 |
| 2024 | Beam Therapeutics Inc. (BEAM) | CMO | $517,500 | $2,615,681 |
| 2023 | Beam Therapeutics Inc. (BEAM) | CMO | $495,000 | $2,545,219 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.